HIGHLIGHTS
- who: Heart failure and colleagues from the University of have published the article: Rationale and design of a randomised trial of intravenous iron in patients with heart failure, in the Journal: (JOURNAL) of 30/09/2020
- what: Allowing for non- cardiovascular mortality and some withdrawals of consent for follow-up, the authors intended to recruit 650 patients per group.
SUMMARY
Patients with heart failure, with or without reduced left ventricular ejection fraction (LVEF), often have anaemia, and this will usually be due to iron deficiency. In patients with heart failure and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.